Targeting two pathways at once: the emerging role of bispecific antibodies in NSCLC and SCLC
Abstract
1. A bispecific antibody (bsAB) is an engineered antibody molecule that possesses two distinct antigen-binding sites, enabling it to simultaneously bind two different antigens or two different epit...
Fields of Study & Subjects
Monoclonal and Polyclonal Antibodies Research
Lung Cancer Research Studies
vaccines and immunoinformatics approaches
Publication details
- Journal / source
- Expert Opinion on Biological Therapy
- Volume
- 26
- Issue
- 1
- Pages
- 5–9
- Publication date
- 2 January 2026
- Language
- EN